Blood cancers

Inappropriate use of PPI prophylaxis is common in haematology patients

Evidence of wide variation in the use of proton pump inhibitors (PPIs) as prophylaxis in haematology patients raises concerns about unnecessary costs and the risk of adverse events. A retrospective review of prescribing practices at the Austin Hospital over 14 months found about 60% of myeloma, lymphoma and autograft patients received PPI prophylaxis during and ...

Already a member?

Login to keep reading.

© 2021 the limbic